September 4th Event to be Co-Hosted by TriStar Technology Ventures, UAMS Innovations and the Natural State Angel Association Nashville, August 31, 2012 – TriStar Technology Ventures is pleased to announce that it will co-host A Showcase of Arkansas Healthcare Innovation & Initiatives on Tuesday, September 4th in conjunction with UAMS Innovations and the Natural State [...]

Limestone Fund, LLC and TriStar Technology Ventures, LLC Start New Diagnostic Company 09/30/2011 NASHVILLE, Tenn., Sept. 30, 2011 /PRNewswire/ – Limestone Fund and TriStar Technology Ventures are pleased to have joined together to form a new company, Diagnovus, LLC, which is headquartered in Nashville, Tennessee. As part of its creation, TriStar and Limestone also completed a seed financing round [...]

Revolutionary New Device Used to Treat Spider and Reticular Veins 07/18/2011 Nashville, July 18, 2011 –VenX, LLC, a medical device company dedicated to revolutionizing the treatment of spider and reticular veins, is pleased to announce that the company has received 510(k) clearance from the FDA for its VenX Revolution™device. “We are very excited about receiving [...]

TriStar Technology Fund, LLC and Limestone Fund, LLC Start New Medical Device Company 03/08/2011 Nashville, March 8, 2011 – TriStar Technology Fund and Limestone Fund are pleased to have joined together to form a new company, Device Innovation Group, LLC, which is headquartered in Nashville, Tennessee. As part of its creation, TriStar and Limestone also completed [...]

World-Renowned Vein Specialist to Lend Expertise to VenX 12/07/2010 Nashville, December 7, 2010 –VenX, LLC, a medical device company dedicated to revolutionizing the treatment of spider and reticular veins, is pleased to announce that Dr. Nick Morrison will join the company’s Scientific Advisory Board. Dr. Nick Morrison is the founder and Medical Director of both [...]

TriStar Funds Further Development of VenX’s Revolutionary Technology to Treat Spider Veins 08/31/2010 Nashville, August 31, 2010 – VenX, LLC, a medical device company dedicated to revolutionizing the treatment of spider and reticular veins, is pleased to announce that it has closed its first institutional round of financing with an investment from TriStar Technology Fund, LLC. [...]